Jeff W. Himawan's most recent trade in Horizon Therapeutics Plc was a trade of 7,873 Ordinary Shares done . Disclosure was reported to the exchange on May 9, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 May 2023 | 7,873 | 7,873 (0%) | 0% | 0 | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 May 2023 | 7,873 | 2,121 (0%) | 0% | 0 | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 11,873 (0%) | 0% | - | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.16 per share. | 28 Apr 2023 | 1,879 | 9,994 (0%) | 0% | 111.2 | 208,870 | Ordinary Shares |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Dec 2022 | 2,230 | 7,960 (0%) | 0% | 0 | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 58,202 (0%) | 0% | - | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,139 | 57,063 (0%) | 0% | 98.6 | 112,260 | Ordinary Shares |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 53,979 (0%) | 0% | - | Ordinary Shares | |
Horizon Therapeutics Plc | Jeff W. Himawan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units |